BDBM419116 5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2-[(2-isothiocyanatophenyl)methyl]-2H-[1,2,3]triazolo[4,5-d]pyrimidine::US10450321, Example 4

SMILES CC(C)(C)c1nc(N2CCC(F)(F)C2)c2nn(Cc3ccccc3SC#N)nc2n1

InChI Key InChIKey=FRHDIUCRVWSMQA-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419116   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419116(5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2-[(2...)
Affinity DataKi:  453nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM419116(5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2-[(2...)
Affinity DataKi: >1.00E+4nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent